Your browser doesn't support javascript.
loading
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
van den Broek, Alexandra J; Schmidt, Marjanka K; van 't Veer, Laura J; Oldenburg, Hester S A; Rutgers, Emiel J; Russell, Nicola S; Smit, Vincent T H B M; Voogd, Adri C; Koppert, Linetta B; Siesling, Sabine; Jobsen, Jan J; Westenend, Pieter J; van Leeuwen, Flora E; Tollenaar, Rob A E M.
Afiliação
  • van den Broek AJ; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • van 't Veer LJ; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Oldenburg HSA; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Rutgers EJ; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Russell NS; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Smit VTHBM; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Voogd AC; Department of Radiotherapy, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Koppert LB; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Jobsen JJ; Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Westenend PJ; Department of Oncological Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Leeuwen FE; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Tollenaar RAEM; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands.
Ann Surg ; 270(2): 364-372, 2019 08.
Article em En | MEDLINE | ID: mdl-29727326
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA de Neoplasias / Mastectomia Radical / Mastectomia Segmentar / Proteína BRCA1 / Proteína BRCA2 / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Surg Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA de Neoplasias / Mastectomia Radical / Mastectomia Segmentar / Proteína BRCA1 / Proteína BRCA2 / Mutação Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Surg Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda